AKTS
Aktis Oncology, Inc.
Pharmaceutical PreparationsNasdaq<br>Emerging growth company
Total Trades
35
Buys
11
Sells
24
Largest Trade
$1M+
Insiders
12
Institutional Funds
2
Inst. Value
$1M+
Activist Filings
9
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Foley Todd | Director | BUY | $1M+ | 233K | $18.00 | Jan 14, 2026 |
| MPM BIOVENTURES 2018, L.P. | 10% Owner | BUY | $1M+ | 1.1M | $18.00 | Jan 14, 2026 |
| GADICKE ANSBERT | 10% Owner | BUY | $1M+ | 1.1M | $18.00 | Jan 14, 2026 |
| EcoR1 Capital, LLC | Director | BUY | $1M+ | 2.2M | $18.00 | Jan 13, 2026 |
| Vida Ventures II, LLC | 10% Owner | BUY | $1M+ | 835K | $18.00 | Jan 12, 2026 |
| Kim Helen Susan | Director | BUY | $1M+ | 835K | $18.00 | Jan 12, 2026 |
| Geiss Arthur | Director | BUY | $15K–$50K | 50K | $0.50 | Jan 31, 2024 |
| Aichele David | EVP of Business De… | BUY | $15K–$50K | 80K | $0.50 | Jan 31, 2024 |
| Boller Kenneth | CFO | BUY | $15K–$50K | 60K | $0.50 | Jan 31, 2024 |
| Shealy Jeffrey B. | CEO | BUY | $500K+ | 1.3M | $0.50 | Jan 31, 2024 |
| Aichele David | EVP of Business De… | SELL | $1K–$15K | 3K | $0.59 | Nov 22, 2023 |
| Boller Kenneth | CFO | SELL | $1K–$15K | 2K | $0.59 | Nov 22, 2023 |
| Boller Kenneth | CFO | SELL | $1K–$15K | 4K | $1.10 | Sep 13, 2023 |
| Aichele David | EVP of Business De… | SELL | $1K–$15K | 5K | $1.09 | Sep 13, 2023 |
| Denbaars Steven | Director | SELL | $1K–$15K | 7K | $1.83 | Aug 22, 2023 |
| Boller Kenneth | CFO | SELL | $1K–$15K | 800 | $4.37 | Feb 14, 2023 |
| Aichele David | EVP of Business De… | SELL | $1K–$15K | 1K | $3.14 | Dec 21, 2022 |
| Boller Kenneth | CFO | SELL | $1K–$15K | 1K | $2.92 | Dec 21, 2022 |
| Shealy Jeffrey B. | CEO | SELL | $1K–$15K | 2K | $2.84 | Dec 21, 2022 |
| Denbaars Steven | Director | SELL | $15K–$50K | 7K | $3.57 | Dec 8, 2022 |
| Shealy Jeffrey B. | CEO | SELL | $1K–$15K | 2K | $3.54 | Nov 28, 2022 |
| Boller Kenneth | CFO | SELL | $1K–$15K | 1K | $3.52 | Nov 28, 2022 |
| Aichele David | EVP of Business De… | SELL | $1K–$15K | 2K | $3.52 | Nov 28, 2022 |
| Shealy Jeffrey B. | CEO | SELL | $15K–$50K | 4K | $4.30 | Sep 12, 2022 |
| Denbaars Steven | Director | SELL | $15K–$50K | 7K | $3.90 | Sep 8, 2022 |
| Boller Kenneth | CFO | SELL | $1K–$15K | 2K | $4.53 | Aug 31, 2022 |
| Aichele David | EVP of Business De… | SELL | $15K–$50K | 4K | $4.53 | Aug 31, 2022 |
| Shealy Jeffrey B. | CEO | SELL | $15K–$50K | 4K | $4.54 | Aug 31, 2022 |
| Boller Kenneth | CFO | SELL | $1K–$15K | 2K | $4.62 | Aug 24, 2022 |
| Aichele David | EVP of Business De… | SELL | $1K–$15K | 1K | $4.62 | Aug 24, 2022 |
| Aichele David | EVP of Business De… | SELL | $1K–$15K | 2K | $3.68 | Jul 20, 2022 |
| Denbaars Steven | Director | SELL | $15K–$50K | 7K | $4.48 | Jun 7, 2022 |
| Aichele David | EVP of Business De… | SELL | $15K–$50K | 5K | $5.93 | Apr 12, 2022 |
| McGuire James Michael | Director | BUY | $100K–$500K | 18K | $5.62 | Feb 8, 2022 |
| Denbaars Steven | Director | SELL | $15K–$50K | 7K | $5.91 | Jan 13, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Sep 30, 2023 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 3.6M | $1M+ | SH |
| CITIGROUP INC | 245 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D · Jan 20, 2026
7.4%
4.0M shares
SC 13D · Jan 15, 2026
11.9%
6.3M shares
SC 13G/A · Nov 12, 2024
2.2%
3.2M shares
SC 13G · Nov 4, 2024
2.2%
3.2M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.0%
3.6M shares
SC 13G · Jan 26, 2024
6.9%
5.0M shares
SC 13G · Sep 14, 2023
5.3%
3.8M shares
SC 13G/A · Mar 8, 2023
4.6%
3.3M shares
SC 13G/A · Feb 1, 2023
5.7%
3.3M shares